Sandu Pharmaceuticals Ltd.

BSE: SANDUPHQ524703ISIN INE751D01014

Healthcare
Pharmaceuticals

BSE listing

Share price

₹37.00+0.24 (+0.65%)

as of 18 Sep 2026

52W high: ₹50.00
52W low: ₹30.00
Off 52W high: -26.00%
1M return: -2.63%
3M return: -13.49%
6M return: +7.37%
1Y return: -22.82%
20D avg volume: 4,049
50 DMA: ₹38.60
200 DMA: ₹38.36

Key ratios Consolidated

Market cap: ₹35.75 Cr
Current price: ₹37.00
52W high / low: ₹50.00 / ₹30.00
Face value: ₹10.00
P/E: 0.00
P/B: —
EPS (TTM): ₹0.00
Book value / share: —
ROE: —
ROCE: 5.20%
Operating margin: —
Net margin: —
Debt / equity: 0.01
Net debt: ₹-0.82 Cr
Interest cover: 22.60
Dividend yield: 2.70%
Dividend / share (TTM): ₹1.00
Payout: —
Cash conversion cycle: 78.4 days

Financials

Metric	Q4 FY25	Q4 FY24
Income statement
	14.07	—
	0.07	—
	13.80	—
	3.01	—
	7.29	—
	2.83	—
	0.03	—
	0.15	—
	5.02	—
	0.34	—
	0.00	—
	0.34	—
	0.02	—
	0.33	—
	0.34	—
Key metrics
	0.52	—
	3.70%	—
	2.30%	—
	0.80%	—

Metric	FY25	FY24
Income statement
	67.19	—
	0.17	—
	65.20	—
	10.12	—
	23.18	—
	10.92	—
	0.10	—
	0.67	—
	21.41	—
	2.16	—
	0.00	—
	2.16	—
	0.61	—
	1.55	—
	1.60	—
Key metrics
	2.93	—
	4.40%	—
	2.30%	—
	5.20%	—
	0.01	—
	0.61	—
	0.01	—
	-0.82	—
	78.4	—
Balance sheet
	55.72	—
	26.30	—
	1.30	—
	4.76	—
	14.15	—
	8.47	—
	4.49	—
	12.09	—
	0.48	—
	0.06	—
	0.42	—
	42.02	—
Cash flow
	0.95	—
	-0.19	—
	-0.46	—
	0.94	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	16.39	16.85	18.76	17.62	16.70	14.07	—
	0.02	0.37	0.01	0.05	0.02	0.07	—
	16.05	16.47	17.92	16.95	16.38	13.80	—
	2.34	3.84	2.81	2.45	1.91	3.01	—
	4.43	3.52	3.50	5.88	3.59	7.29	—
	2.79	2.74	2.65	2.64	2.66	2.83	—
	0.03	0.03	0.03	0.03	0.03	0.03	—
	0.16	0.16	0.17	0.17	0.18	0.15	—
	6.52	7.01	7.19	5.79	4.68	5.02	—
	0.36	0.75	0.85	0.71	0.34	0.34	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.36	0.75	0.85	0.71	0.34	0.34	—
	0.13	0.70	-0.12	0.19	0.12	0.02	—
	0.23	0.04	0.98	0.52	0.22	0.33	—
	0.37	0.04	1.01	0.54	0.23	0.34	—
Key metrics
	0.55	0.94	1.05	0.91	0.55	0.52	—
	3.40%	5.60%	5.60%	5.20%	3.30%	3.70%	—
	1.40%	0.20%	5.20%	3.00%	1.30%	2.30%	—
	—	1.70%	—	1.70%	—	0.80%	—
	-1.90%	19.80%	—	—	—	—	—
	4.50%	-87.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	69.62	69.93	67.19	—
	0.45	0.44	0.17	—
	67.39	67.72	65.20	—
	11.44	11.01	10.12	—
	17.33	16.48	23.18	—
	10.82	10.69	10.92	—
	0.12	0.11	0.10	—
	0.66	0.68	0.67	—
	26.51	24.67	21.41	—
	2.67	2.66	2.16	—
	0.00	0.00	0.00	—
	2.67	2.66	2.16	—
	0.90	0.89	0.61	—
	1.77	1.77	1.55	—
	1.96	1.83	1.60	—
Key metrics
	3.45	3.45	2.93	—
	4.96%	4.90%	4.40%	—
	2.54%	2.50%	2.30%	—
	—	6.10%	5.20%	—
	—	4.10%	—	—
	—	14.20%	—	—
	—	5.40	0.01	—
	—	3.46	0.61	—
	—	0.01	0.00	—
	—	-5.49	-1.24	—
	—	59.5	78.4	—
Balance sheet
	—	55.87	55.72	—
	—	25.32	26.30	—
	—	5.91	1.30	—
	—	5.41	4.76	—
	—	10.47	14.15	—
	—	2.58	4.74	—
	—	8.68	8.47	—
	—	4.47	4.49	—
	—	10.42	12.09	—
	—	0.42	0.06	—
	—	0.11	0.06	—
	—	0.31	0.00	—
	—	43.67	42.02	—
Cash flow
	—	6.12	0.95	—
	—	-0.57	-0.18	—
	—	-0.94	-0.46	—
	—	0.72	0.94	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 37.78%

Holder	Type	Holding	Previous	Change
UMESH BHASKAR SANDU	Promoter	14.37%	—	—
SHASHANK BHASKAR SANDU	Promoter	14.17%	—	—
JAYSHREE BHASKAR SANDU	Promoter	7.63%	—	—
SANMARK REALTY AND FINANCE PRIVATE LIMITED	Public	5.63%	—	—
AKSHATH FINVEST AND PROPERTIES PRIVATE LIMITED	Public	5.12%	—	—
NEELAMBER LEASING AND FINVEST PRIVATE LIMITED	Public	4.71%	—	—
TANVI JIGNESH MEHTA	Public	4.61%	—	—
SANBRO MARKETING SERVICES PVT LTD	Public	2.59%	—	—
NOUMURA REALTY AND CONSTRUCTIONS PRIVATE LIMITED	Public	2.27%	—	—
PHYBRICHEM ENGINEERS PRIVATE LIMITED	Public	1.61%	—	—
HITESH KUVELKAR	Public	1.26%	—	—
GEETA U SANDU	Promoter	0.88%	—	—
MINAL SHASHANK SANDU	Promoter	0.63%	—	—
SHUBHADA PRABHAKAR SANDU	Promoter	0.10%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director12 Sep 2026 · Company Update / Change in Directorate
Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting12 Sep 2026 · Company Update / Appointment of Statutory Auditor/s
41st Annual General Meeting scrutinizers Report12 Sep 2026 · AGM/EGM / AGM
Proceedings of the 41st Annual General Meeting held on Friday 11th september 2026 at 04:30 pm11 Sep 2026 · AGM/EGM / AGM
Newspaper Publication opening of special window for re-lodgement of transfer request for physical shares4 Sep 2026 · Company Update / Newspaper Publication
Newspaper Advertisement intimating shareholders about Notice of Annual General Meeting and Evoting20 Aug 2026 · Company Update / Newspaper Publication
Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA19 Aug 2026 · Company Update / General
41st Annual Report of Sandu Pharmaceuticals Limited19 Aug 2026 · Others / Reg. 34 (1) Annual Report
Intimation about Annual General Meeting19 Aug 2026 · AGM/EGM / AGM
Newspaper Advertisement Pre despatch of Annual Report intimation to Shareholders14 Aug 2026 · Company Update / Newspaper Publication
Newspaper Publication Unaudited Financials for Q ended 30th June 202613 Aug 2026 · Company Update / Newspaper Publication
approval of material related party transactions subject to approval of shareholder11 Aug 2026 · Company Update / General
statement of deviation and utlisation of funds for q ended 30.06.202611 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Appointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder11 Aug 2026 · Company Update / Change in Management
Intimation about the date of the annual General Meeting11 Aug 2026 · Company Update / General
Intimation about the Record date11 Aug 2026 · Corp. Action / Record Date
Intimation about Book closure for AGM11 Aug 2026 · Corp. Action / Book Closure
Outcome and results of the Board Meeting dated 11.08.202611 Aug 2026 · Company Update / General
Unaudited Financials For ended 30.06.202611 Aug 2026 · Result / Financial Results
Outcome of the Board Meeting 11.08.202611 Aug 2026 · Company Update / General
Outcome of the Board Meeting11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1.To consider and approve ....3 Aug 2026 · Board Meeting / Board Meeting
Reconstitution of Committees of Board-Audit/Nomination/Stakeholders11 Jul 2026 · Company Update / General
1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company 2.Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman ....11 Jul 2026 · Company Update / Change in Directorate
Outcome of the Board Meeting dated 11.07.202611 Jul 2026 · Board Meeting / Outcome of Board Meeting
newspaper publication-opening of special window for relodgment of special window for transfer of shares and second 100 days campaign saksham niveshak8 Jul 2026 · Company Update / Newspaper Publication
Certificate under Regulation 74(5) of SEBI(DP) Regulation7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve 1. To place on record ....6 Jul 2026 · Board Meeting / Board Meeting
intimation about closure of trading window for q ended 30th June 202624 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
demise of Shri Umesh Sandu, Managing Director (DIN:01132141) revised disclosure20 Jun 2026 · Company Update / General
Sad demise of Shri Umesh Sandu (DIN:01132141) Managing Director of the company19 Jun 2026 · Company Update / Change in Directorate
sad demise of Shri Umesh Sandu as Managing Director(DIN:01132141)19 Jun 2026 · Company Update / Cessation
Intimation about sad demise of our Managing Director ,Shri Umesh Sandu(DIN:01132141)19 Jun 2026 · Company Update / Demise
Newspaper Publication for opening of special window for re lodgment of transfer requests for physical shares and Second 100 days campaign Saksham Niveshak creating awareness amongst ....6 Jun 2026 · Company Update / Newspaper Publication
Annual Secretarial Compliance Report for Year ended 31st March 202618 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Demand order from office of assistant commissioner, due to discrepancy in quantity as per invoice and quantity as per physical verification of Goods7 May 2026 · Company Update / General
Newspaper Publication for Audited Financials for the Q and Year ended 31.03.20267 May 2026 · Company Update / Newspaper Publication
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....5 May 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Statement of Deviation and Variation of Funds for q ended 31.03.20265 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Re-appointment of Internal Auditors and Cost Auditor for the FY 2026-275 May 2026 · Company Update / Change in Management

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.0000	4 Sep 2026	4 Sep 2026	—
Final Dividend - Rs. - 0.8000	18 Sep 2025	18 Sep 2025	—
Final Dividend - Rs. - 0.8000	19 Sep 2024	—	—

Board meetings

11 Aug 2026 Board Meeting - Financial Results